Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Extended-release Exenatide in Diabetic, HIV-infected Adults
NCT01791465Phase 4Terminated
- Sponsor
- Vanderbilt University
- Start
- Mar 2013
- Primary completion
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Vanderbilt University. Started Mar 2013; status: terminated.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01791465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791465.